Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AERO-007 Phase 1/2a in Healthy Volunteers and COPD
NCT06841640Phase 2Completed
- Sponsor
- AeroRx Therapeutics
- Start
- Jan 2025
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AERO-007 in chronic obstructive pulmonary disease (COPD), sponsored by AeroRx Therapeutics. Started Jan 2025; status: completed.
02
Drugs
AERO-007
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT06841640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06841640.